M. Pesek (Pilsen, Czech Republic)
Negative predictive value of autofluorescence imaging (AFI) in patients at high risk for lung cancer
O. Bauwens, P. Pierard, J. Faber, T. Prigogine, J. P. Sculier, V. Ninane (Brussels, Belgium)
|   |
Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis
G. Fernandez, J. Sanchez de Cos, J. C. Serrano, E. Garcia, I. Utrabo, C. Disdier (Caceres, Spain)
| |
Antigen a in blood correlates with improved survival in resected NSCLC patients
A. Kuemmel, K. Single, L. H. Schmidt, W. Hitzler, M. Sebastian, C. Taube, R. Buhl, R. Wiewrodt (Mainz, Germany)
| |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
M. Petrovic, I. Tomic, S. Ilic, N. Ilic, I. Cekerevac (Kragujevac, Belgrade, Serbia And Montenegro)
| |
Correlation between standardised uptake value on PET scans, tumour characteristics and survival in resected lung cancer patients
L. Sundararajan, S. Esampalli, A. Hakeem, C. Ramesh, S. Vinjamuri, M. J. Ledson, M. J. Walshaw (Liverpool, United Kingdom)
| |
Contribuation of bioelectrical impedance analysis (BIA) in lung cancer
L. Alouane, A. Bedoui, O. Kahloul, H. Daghfous, F. Tritar (Tunis, Ariana, Tunisia)
| |
Prognostic factors in patients with lung cancer and brain metastases at presentation
S. Saleiro, C. Damas, M. Marques, S. Pereira, H. Queiroga (Porto, Portugal)
| |
Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters
M. Cekic, M. Rancic (Nis, Serbia And Montenegro)
| |
Correlation between tumour size and survival in surgically treated patients with lung cancer, stage IA or B
F. Vlastos, S. Lacomme, J. M. Vignaud, Y. Martinet, N. Martinet (Nancy, France)
| |
Comorbidity related to age and gender in lung cancer patients
S. Djordjevic, M. Radovic, M. Cekic, I. Djordjevic, S. Rancic (Nis, Serbia And Montenegro)
| |
Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients
F. H. M. van Vollenhoven, T. A. G. M. van de Looi, Y. Berk, M. E. Keemers- Gels, Y. F. Heijdra, J. P. Janssen (Nijmegen, Netherlands)
| |
Lung cancer in women: 44 cases
S. Djordjevic, M. Cekic, T. Radjenovic, M. Rancic, I. Djordjevic (Nis, Serbia And Montenegro)
| |
Multiple carcinomas in the lung cancer patients
D. Jancarikova, M. Pesek (Pilsen, Czech Republic)
| |
Uveal metastasis of bronchogenic carcinoma – case report
C. Alcobia, M. J. Guimarães, P. Loureiro, G. Silva, A. Szantho, M. Loureiro, M. Baganha (Coimbra, Portugal)
| |
Mediastinal lymphoma
H. Hassene, D. Belhabib, L. Fekih, S. Feniche, L. Megdiche (Ariana, Tunisia)
| |
Biochemical and cytological features of metastatic pleural effusions in breast cancer
M. Medenica (Niksic, Serbia And Montenegro)
| |
Auto-fluorescence bronchoscopy is better than white-light bronchoscopy in detecting pre-malignant mucosal lesions in non-Caucasian patients
K. Hui, J. Tan (Orchard Road, Simei, Singapore)
| |
Correlation between pleural cytology, radiolgy and histology in mesothelioma: a 3 year retrospective study
H. Ramadan (Portsmouth, United Kingdom)
| |
Mesothelial reactive hyperplasia of the pleura: the dilemma between a malign or benign disease
C. Guevara, I. M. Ballarin, R. Llatjos (Barcelona, Spain)
| |